RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 77 filers reported holding RECRO PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $597,000 | +160.7% | 32,570 | +57.6% | 0.27% | +111.6% |
| Q3 2019 | $229,000 | +12.3% | 20,670 | +3.2% | 0.13% | +14.2% |
| Q2 2019 | $204,000 | -45.0% | 20,024 | -68.4% | 0.11% | -46.9% |
| Q1 2019 | $371,000 | +15.2% | 63,378 | +39.7% | 0.21% | -0.5% |
| Q4 2018 | $322,000 | -2.7% | 45,367 | -2.7% | 0.21% | +12.6% |
| Q3 2018 | $331,000 | +34.0% | 46,616 | -5.3% | 0.19% | +25.0% |
| Q2 2018 | $247,000 | -80.3% | 49,242 | -56.8% | 0.15% | -80.6% |
| Q1 2018 | $1,255,000 | +20.9% | 113,945 | +1.5% | 0.78% | +15.8% |
| Q4 2017 | $1,038,000 | +11.0% | 112,265 | +7.8% | 0.68% | +11.9% |
| Q3 2017 | $935,000 | +32.8% | 104,145 | +4.0% | 0.60% | +22.2% |
| Q2 2017 | $704,000 | – | 100,147 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 3,510,000 | $6,318,000 | 5.40% |
| Cowen Prime Advisors LLC | 4,162,500 | $7,493,000 | 3.15% |
| Athyrium Capital Management, LP | 2,202,420 | $3,964,000 | 1.41% |
| AWM Investment Company, Inc. | 5,081,901 | $9,147,000 | 1.18% |
| Parkman Healthcare Partners LLC | 671,817 | $1,209,000 | 0.35% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 799,841 | $1,440,000 | 0.18% |
| Rubric Capital Management LP | 1,076,587 | $1,938,000 | 0.07% |
| TITLEIST CAPITAL, LLC | 180,093 | $324,000 | 0.06% |
| Clear Harbor Asset Management, LLC | 266,972 | $481,000 | 0.06% |
| Frontier Wealth Management LLC | 64,605 | $2,701,000 | 0.03% |